Interestingly, we found that MARCH8 promoter is hypermethylated in pancreatic tumor samples compared to normal pancreatic samples (Fig. 8A) and consequently, the expression of MARCH8 is lower in tumor samples compared to normal pancreatic samples (Fig. 8B). Here, MARCHF8 is linked to neoplasm.